Skip to main navigation Skip to search Skip to main content

Toll-like receptors in rheumatic diseases: Are we paying a high price for our defense against bugs?

  • K. C.M. Santegoets
  • , L. Van Bon
  • , W. B. Van Den Berg
  • , M. H. Wenink
  • , T. R.D.J. Radstake*
  • *Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

26 Citations (Scopus)

Abstract

In the last decade Toll-like receptor (TLR) research has led to new insights in the pathogenesis of many rheumatic diseases. In autoimmune diseases like systemic lupus erythematosus, rheumatoid arthritis and systemic sclerosis TLR signaling is likely to be involved in tolerance breakthrough and chronic inflammation via combined Fc gamma receptors and TLR recognition of immune complexes. Furthermore, inflammatory diseases like psoriatic arthritis and gout also show more and more evidence for TLR involvement. In this review we will discuss the involvement of TLR signaling in several rheumatic diseases and stress their similarities and differences based on recent findings.

Original languageEnglish
Pages (from-to)3660-3666
Number of pages7
JournalFEBS letters
Volume585
Issue number23
DOIs
Publication statusPublished - 1 Dec 2011

Keywords

  • Autoimmunity
  • Innate immunity
  • Rheumatologic disease
  • Toll-like receptor

Fingerprint

Dive into the research topics of 'Toll-like receptors in rheumatic diseases: Are we paying a high price for our defense against bugs?'. Together they form a unique fingerprint.

Cite this